THSD1 preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE-/- mice

Remco A Haasdijk; Wijnand K Den Dekker; Caroline Cheng; Dennie Tempel; Robert Szulcek; Frank L Bos; Dorien M A Hermkens; Ihsan Chrifi; Maarten M Brandt; Chris Van Dijk; Yan Juan Xu; Esther H M Van De Kamp; Lau A J Blonden; Jan Van Bezu; Judith C Sluimer; Erik A L Biessen; Geerten P Van Nieuw Amerongen; Henricus J Duckers

doi:10.1093/cvr/cvw015

THSD1 preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE-/- mice

Remco A Haasdijk
, Wijnand K Den Dekker
, Caroline Cheng
, Dennie Tempel
, Robert Szulcek
, Frank L Bos
, Dorien M A Hermkens
, Ihsan Chrifi
, Maarten M Brandt
, Chris Van Dijk
, Yan Juan Xu
, Esther H M Van De Kamp
, Lau A J Blonden
, Jan Van Bezu
, Judith C Sluimer
, Erik A L Biessen
, Geerten P Van Nieuw Amerongen
, Henricus J Duckers

Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands.
Department of Cardiology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands Regenerative Vascular Medicine Laboratory, Department of Nephrology and Hypertension, Division of Internal Medicine and Dermatology, University Medical Center Utrecht, Heidelberglaan 100, PO Box 85500, 3584 CX Utrecht, 3508 GA Utrecht, The Netherlands.
Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Cardiology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands Hubrecht Institute, Utrecht, The Netherlands.
Regenerative Vascular Medicine Laboratory, Department of Nephrology and Hypertension, Division of Internal Medicine and Dermatology, University Medical Center Utrecht, Heidelberglaan 100, PO Box 85500, 3584 CX Utrecht, 3508 GA Utrecht, The Netherlands.
Department of Physiology, Institute for Cardiovascular Research, VU University Medical Center, De Boelelaan 1118, Room 11W53, 1081 HV, Amsterdam, The Netherlands.
Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands.
Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands [email protected].

Research output: Contribution to journal › Article › Academic › peer-review

30 Downloads (Pure)

Abstract

AIMS: Impairment of the endothelial barrier leads to microvascular breakdown in cardiovascular disease and is involved in intraplaque haemorrhaging and the progression of advanced atherosclerotic lesions that are vulnerable to rupture. The exact mechanism that regulates vascular integrity requires further definition. Using a microarray screen for angiogenesis-associated genes during murine embryogenesis, we identified thrombospondin type I domain 1 (THSD1) as a new putative angiopotent factor with unknown biological function. We sought to characterize the role of THSD1 in endothelial cells during vascular development and cardiovascular disease.

METHODS AND RESULTS: Functional knockdown of Thsd1 in zebrafish embryos and in a murine retina vascularization model induced severe haemorrhaging without affecting neovascular growth. In human carotid endarterectomy specimens, THSD1 expression by endothelial cells was detected in advanced atherosclerotic lesions with intraplaque haemorrhaging, but was absent in stable lesions, implying involvement of THSD1 in neovascular bleeding. In vitro, stimulation with pro-atherogenic factors (3% O2 and TNFα) decreased THSD1 expression in human endothelial cells, whereas stimulation with an anti-atherogenic factor (IL10) showed opposite effect. Therapeutic evaluation in a murine advanced atherosclerosis model showed that Thsd1 overexpression decreased plaque vulnerability by attenuating intraplaque vascular leakage, subsequently reducing macrophage accumulation and necrotic core size. Mechanistic studies in human endothelial cells demonstrated that THSD1 activates FAK-PI3K, leading to Rac1-mediated actin cytoskeleton regulation of adherens junctions and focal adhesion assembly.

CONCLUSION: THSD1 is a new regulator of endothelial barrier function during vascular development and protects intraplaque microvessels against haemorrhaging in advanced atherosclerotic lesions.

Original language	English
Pages (from-to)	129-39
Number of pages	11
Journal	Cardiovascular research
Volume	110
Issue number	1
DOIs	https://doi.org/10.1093/cvr/cvw015
Publication status	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Animals
Apolipoproteins E
Atherosclerosis
Carotid Artery Diseases
Endothelial Cells
Female
Humans
Male
Mice, Inbred C57BL
Microvessels
Neovascularization, Pathologic
Phosphatidylinositol 3-Kinases
Plaque, Atherosclerotic
Thrombospondin 1
Thrombospondins
Journal Article
Research Support, Non-U.S. Gov't

Access to Document

10.1093/cvr/cvw015

Thsd1-preserves-vascular-integrity-and-protects-against-intraplaque-haemorrhaging-in-apoe---mice.pdfFinal published version, 1.26 MBLicence: Taverne

Cite this

Haasdijk, R. A., Den Dekker, W. K., Cheng, C., Tempel, D., Szulcek, R., Bos, F. L., Hermkens, D. M. A., Chrifi, I., Brandt, M. M., Van Dijk, C., Xu, Y. J., Van De Kamp, E. H. M., Blonden, L. A. J., Van Bezu, J., Sluimer, J. C., Biessen, E. A. L., Van Nieuw Amerongen, G. P., & Duckers, H. J. (2016). THSD1 preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE-/- mice. Cardiovascular research, 110(1), 129-39. https://doi.org/10.1093/cvr/cvw015

@article{40f520e885cf4f13927ef559dd66bac8,

title = "THSD1 preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE-/- mice",

abstract = "AIMS: Impairment of the endothelial barrier leads to microvascular breakdown in cardiovascular disease and is involved in intraplaque haemorrhaging and the progression of advanced atherosclerotic lesions that are vulnerable to rupture. The exact mechanism that regulates vascular integrity requires further definition. Using a microarray screen for angiogenesis-associated genes during murine embryogenesis, we identified thrombospondin type I domain 1 (THSD1) as a new putative angiopotent factor with unknown biological function. We sought to characterize the role of THSD1 in endothelial cells during vascular development and cardiovascular disease.METHODS AND RESULTS: Functional knockdown of Thsd1 in zebrafish embryos and in a murine retina vascularization model induced severe haemorrhaging without affecting neovascular growth. In human carotid endarterectomy specimens, THSD1 expression by endothelial cells was detected in advanced atherosclerotic lesions with intraplaque haemorrhaging, but was absent in stable lesions, implying involvement of THSD1 in neovascular bleeding. In vitro, stimulation with pro-atherogenic factors (3\% O2 and TNFα) decreased THSD1 expression in human endothelial cells, whereas stimulation with an anti-atherogenic factor (IL10) showed opposite effect. Therapeutic evaluation in a murine advanced atherosclerosis model showed that Thsd1 overexpression decreased plaque vulnerability by attenuating intraplaque vascular leakage, subsequently reducing macrophage accumulation and necrotic core size. Mechanistic studies in human endothelial cells demonstrated that THSD1 activates FAK-PI3K, leading to Rac1-mediated actin cytoskeleton regulation of adherens junctions and focal adhesion assembly.CONCLUSION: THSD1 is a new regulator of endothelial barrier function during vascular development and protects intraplaque microvessels against haemorrhaging in advanced atherosclerotic lesions.",

keywords = "Animals, Apolipoproteins E, Atherosclerosis, Carotid Artery Diseases, Endothelial Cells, Female, Humans, Male, Mice, Inbred C57BL, Microvessels, Neovascularization, Pathologic, Phosphatidylinositol 3-Kinases, Plaque, Atherosclerotic, Thrombospondin 1, Thrombospondins, Journal Article, Research Support, Non-U.S. Gov't",

author = "Haasdijk, \{Remco A\} and \{Den Dekker\}, \{Wijnand K\} and Caroline Cheng and Dennie Tempel and Robert Szulcek and Bos, \{Frank L\} and Hermkens, \{Dorien M A\} and Ihsan Chrifi and Brandt, \{Maarten M\} and \{Van Dijk\}, Chris and Xu, \{Yan Juan\} and \{Van De Kamp\}, \{Esther H M\} and Blonden, \{Lau A J\} and \{Van Bezu\}, Jan and Sluimer, \{Judith C\} and Biessen, \{Erik A L\} and \{Van Nieuw Amerongen\}, \{Geerten P\} and Duckers, \{Henricus J\}",

year = "2016",

doi = "10.1093/cvr/cvw015",

language = "English",

volume = "110",

pages = "129--39",

journal = "Cardiovascular research",

issn = "0008-6363",

publisher = "Oxford University Press",

number = "1",

}

Haasdijk, RA, Den Dekker, WK, Cheng, C, Tempel, D, Szulcek, R, Bos, FL, Hermkens, DMA, Chrifi, I, Brandt, MM, Van Dijk, C, Xu, YJ, Van De Kamp, EHM, Blonden, LAJ, Van Bezu, J, Sluimer, JC, Biessen, EAL, Van Nieuw Amerongen, GP & Duckers, HJ 2016, 'THSD1 preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE-/- mice', Cardiovascular research, vol. 110, no. 1, pp. 129-39. https://doi.org/10.1093/cvr/cvw015

TY - JOUR

T1 - THSD1 preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE-/- mice

AU - Haasdijk, Remco A

AU - Den Dekker, Wijnand K

AU - Cheng, Caroline

AU - Tempel, Dennie

AU - Szulcek, Robert

AU - Bos, Frank L

AU - Hermkens, Dorien M A

AU - Chrifi, Ihsan

AU - Brandt, Maarten M

AU - Van Dijk, Chris

AU - Xu, Yan Juan

AU - Van De Kamp, Esther H M

AU - Blonden, Lau A J

AU - Van Bezu, Jan

AU - Sluimer, Judith C

AU - Biessen, Erik A L

AU - Van Nieuw Amerongen, Geerten P

AU - Duckers, Henricus J

PY - 2016

Y1 - 2016

N2 - AIMS: Impairment of the endothelial barrier leads to microvascular breakdown in cardiovascular disease and is involved in intraplaque haemorrhaging and the progression of advanced atherosclerotic lesions that are vulnerable to rupture. The exact mechanism that regulates vascular integrity requires further definition. Using a microarray screen for angiogenesis-associated genes during murine embryogenesis, we identified thrombospondin type I domain 1 (THSD1) as a new putative angiopotent factor with unknown biological function. We sought to characterize the role of THSD1 in endothelial cells during vascular development and cardiovascular disease.METHODS AND RESULTS: Functional knockdown of Thsd1 in zebrafish embryos and in a murine retina vascularization model induced severe haemorrhaging without affecting neovascular growth. In human carotid endarterectomy specimens, THSD1 expression by endothelial cells was detected in advanced atherosclerotic lesions with intraplaque haemorrhaging, but was absent in stable lesions, implying involvement of THSD1 in neovascular bleeding. In vitro, stimulation with pro-atherogenic factors (3% O2 and TNFα) decreased THSD1 expression in human endothelial cells, whereas stimulation with an anti-atherogenic factor (IL10) showed opposite effect. Therapeutic evaluation in a murine advanced atherosclerosis model showed that Thsd1 overexpression decreased plaque vulnerability by attenuating intraplaque vascular leakage, subsequently reducing macrophage accumulation and necrotic core size. Mechanistic studies in human endothelial cells demonstrated that THSD1 activates FAK-PI3K, leading to Rac1-mediated actin cytoskeleton regulation of adherens junctions and focal adhesion assembly.CONCLUSION: THSD1 is a new regulator of endothelial barrier function during vascular development and protects intraplaque microvessels against haemorrhaging in advanced atherosclerotic lesions.

AB - AIMS: Impairment of the endothelial barrier leads to microvascular breakdown in cardiovascular disease and is involved in intraplaque haemorrhaging and the progression of advanced atherosclerotic lesions that are vulnerable to rupture. The exact mechanism that regulates vascular integrity requires further definition. Using a microarray screen for angiogenesis-associated genes during murine embryogenesis, we identified thrombospondin type I domain 1 (THSD1) as a new putative angiopotent factor with unknown biological function. We sought to characterize the role of THSD1 in endothelial cells during vascular development and cardiovascular disease.METHODS AND RESULTS: Functional knockdown of Thsd1 in zebrafish embryos and in a murine retina vascularization model induced severe haemorrhaging without affecting neovascular growth. In human carotid endarterectomy specimens, THSD1 expression by endothelial cells was detected in advanced atherosclerotic lesions with intraplaque haemorrhaging, but was absent in stable lesions, implying involvement of THSD1 in neovascular bleeding. In vitro, stimulation with pro-atherogenic factors (3% O2 and TNFα) decreased THSD1 expression in human endothelial cells, whereas stimulation with an anti-atherogenic factor (IL10) showed opposite effect. Therapeutic evaluation in a murine advanced atherosclerosis model showed that Thsd1 overexpression decreased plaque vulnerability by attenuating intraplaque vascular leakage, subsequently reducing macrophage accumulation and necrotic core size. Mechanistic studies in human endothelial cells demonstrated that THSD1 activates FAK-PI3K, leading to Rac1-mediated actin cytoskeleton regulation of adherens junctions and focal adhesion assembly.CONCLUSION: THSD1 is a new regulator of endothelial barrier function during vascular development and protects intraplaque microvessels against haemorrhaging in advanced atherosclerotic lesions.

KW - Animals

KW - Apolipoproteins E

KW - Atherosclerosis

KW - Carotid Artery Diseases

KW - Endothelial Cells

KW - Female

KW - Humans

KW - Male

KW - Mice, Inbred C57BL

KW - Microvessels

KW - Neovascularization, Pathologic

KW - Phosphatidylinositol 3-Kinases

KW - Plaque, Atherosclerotic

KW - Thrombospondin 1

KW - Thrombospondins

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1093/cvr/cvw015

DO - 10.1093/cvr/cvw015

M3 - Article

SN - 0008-6363

VL - 110

SP - 129

EP - 139

JO - Cardiovascular research

JF - Cardiovascular research

IS - 1

ER -

THSD1 preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE-/- mice

Abstract

UN SDGs

Keywords

Access to Document

Fingerprint

Cite this